Concepedia

Author

Kristine Misund

Norwegian University of Science and TechnologyORCID

Also Known As

K Misund, K. Misund, Kristine Misund, Kristine Misund (440096), MMRF CoMMpass Network, Misund, Kristine, Mutolo, D

94

Publications

1.6K

Citations

23

H-Index

61

Concepts

All Affiliations

Norwegian University of Science and TechnologySt Olav's University HospitalUniversity of OsloOslo University HospitalUniversity of Bergen
KM

About

Kristine Misund is an author at Norwegian University of Science and Technology specializing in medicine, cell biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

505

2

Cell Biology

10

10

458

3

Health Sciences

2

2

52

4

Biochemistry

2

2

119

5

Natural Sciences

1

1

95

Kristine Misund

×

32

Publications

1.3K

Citations

23

H-Index

YearCitations

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

Rui Yang, Samah Elsaadi, Kristine Misund,

Journal for ImmunoTherapy of Cancer

2020

114

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells

Rebekka Müller, Kristine Misund, Toril Holien,

PLoS ONE

2013

101

The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells

Ida Johansson, Vivi Talstad Monsen, Kristine Pettersen,

Autophagy

2015

95

Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress

Voin Petrović, Anala Nepal, Camilla Olaisen,

Nutrients

2018

80

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Muhammad Asif Zahoor, Marita Westhrin, Kristin Roseth Aass,

Blood Advances

2017

72

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells

Kristian K. Starheim, Toril Holien, Kristine Misund,

Blood Cancer Journal

2016

66

BMPR2 inhibits activin and BMP signaling via wild-type ALK2

Oddrun Elise Olsen, Meenu Sankar, Samah Elsaadi,

Journal of Cell Science

2018

58

Monitoring multiple myeloma by quantification of recurrent mutations in serum

Even H. Rustad, Eivind Coward, Emilie Ranheim Skytøen,

Haematologica

2017

57

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids

Huabo Wang, Peter Teriete, Angela Hu,

Oncotarget

2015

55

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin

Oddrun Elise Olsen, Karin Fahl Wader, Kristine Misund,

Blood Cancer Journal

2014

54

Page 1